Idexx Laboratories (IDXX) EPS (Basic) (2009 - 2026)

Idexx Laboratories' EPS (Basic) history runs 18 years deep, the most recent figure standing at $3.5 for Q1 2026.

• In Q1 2026, EPS (Basic) rose 17.15% year-over-year to $3.5; the TTM figure through Mar 2026 stood at $13.75 (up 24.94% YoY), while the FY2025 annual figure was $13.17, up 22.35% from the prior year.
• EPS (Basic) for Q1 2026 stood at $3.5, up from $3.09 in the prior quarter.
• The five-year high for EPS (Basic) was $3.66 in Q2 2025, with the low at $1.57 in Q2 2022.
• The 5-year median for EPS (Basic) is $2.62 (2024), against an average of $2.69.
• The sharpest annual moves came in 2022 and 2023: EPS (Basic) tumbled 33.77% in 2022, then surged 71.61% in 2023.
• Idexx Laboratories' EPS (Basic) stood at $2.06 in 2022, then climbed by 13.72% to $2.34 in 2023, then rose by 11.93% to $2.62 in 2024, then climbed by 17.74% to $3.09 in 2025, then gained by 13.29% to $3.5 in 2026.
• Business Quant data shows IDXX's EPS (Basic) at $3.5 in Q1 2026, $3.09 in Q4 2025, and $3.43 in Q3 2025.